CollPlant Biotechnologies Ltd — Cash Flow (NASDAQ:CLGN)

Financials

Cash from operating activities 4.45 M2.5 M13.7 M2.76 M14.09 M — Cash from investing activities 519 K31.56 M28.92 M1.16 M539 K — Cash from financing activities 4.46 M38.76 M1.87 M1.11 M9 000 — Free cash flow 3.93 M912 K12.38 M1.81 M13.61 M —

新闻

CollPlant secures Korean patent for dermal filler technology

CollPlant推出用于3D生物打印的BioFlex生物墨水套装

CollPlant launches BioFlex bioink kit for 3D bioprinting

H.C. Wainwright重申Opko Health股票买入评级

D. Boral Capital将CollPlant评级从买入下调至持有

CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital

CollPlant Biotechnologies定于12月31日召开年度和特别会议

CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31

Collplant ADRQ3每股收益及营收逊于预期

Collplant ADR earnings missed by $0.41, revenue fell short of estimates

CollPlant股价小幅下跌，第三季度收入未达预期

CollPlant shares edge down as Q3 revenue falls short of estimates